Loss of Function
Dyslipidemia
Genotype
ldlr KO, Apo2 KO
Mechanism
Loss of Function
Phenotype
Locomotor activity, Darting behavior, Anxiety, Fatigue, Touch evoke response
Biomarker
Total cholesterol, LDL, HDL, Free fatty acides, Triglycerides
Gene Expression Markers
ldlr, apoa2, apob, apoe, pparα, cpt1a, nrf2, sod1, gpx1
Physiology Changes
Lipid accumulation, Oxidative stress, Liver enlargement
Histology Grading Endpoint
Hepatic steatosis, Vacuolated hepatocytes, Fibrosis, Inflammatory cell infiltration



